Deutsche Bank AG Makes New Investment in DaVita Inc. $DVA

Key Points

• Deutsche Bank acquired 208,362 DaVita shares worth approximately $46.4 million, giving it about a 0.33% stake. Institutional investors collectively own 90.12% of the company.
• DaVita exceeded quarterly expectations, reporting $4.02 in earnings per share versus the $3.88 consensus and $3.55 billion in revenue. Revenue increased 5.2% year over year, and management guided to fiscal 2026 EPS of $14.10–$15.20.
• Analyst sentiment was mixed but included recent price-target increases from TD Cowen and UBS; the stock carries an overall “Hold” rating with an average target of $221.75. Insider Kathleen Alyce Waters also sold 15,405 shares for about $3.2 million.

Deutsche Bank AG purchased a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 208,362 shares of the company's stock, valued at approximately $46,356,000. Deutsche Bank AG owned about 0.33% of DaVita as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of DVA. Root Financial Partners LLC boosted its position in DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company's stock worth $29,000 after purchasing an additional 105 shares during the period. Caitlin John LLC acquired a new stake in shares of DaVita in the fourth quarter valued at about $34,000. Sankala Group LLC bought a new stake in DaVita during the 4th quarter valued at approximately $39,000. Canada Pension Plan Investment Board acquired a new stake in DaVita in the 2nd quarter valued at approximately $43,000. Finally, Kestra Advisory Services LLC acquired a new stake in DaVita in the 4th quarter valued at approximately $45,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Insider Transactions at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of the business's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the transaction, the insider directly owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.90% of the stock is owned by corporate insiders.

DaVita Trading Down 0.6%

NYSE DVA opened at $174.21 on Friday. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $247.49. The company has a market capitalization of $11.11 billion, a price-to-earnings ratio of 14.26, a PEG ratio of 0.58 and a beta of 0.88. The stock's 50 day moving average is $214.96 and its two-hundred day moving average is $181.53.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share for the quarter, beating analysts' consensus estimates of $3.88 by $0.14. The firm had revenue of $3.55 billion for the quarter, compared to analysts' expectations of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The business's revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the business posted $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, analysts predict that DaVita Inc. will post 14.57 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Zacks Research downgraded shares of DaVita from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 6th. TD Cowen raised shares of DaVita from a "hold" rating to a "buy" rating and increased their price target for the company from $201.00 to $220.00 in a report on Friday, August 7th. UBS Group raised their price target on shares of DaVita from $235.00 to $270.00 and gave the stock a "buy" rating in a research report on Friday, July 10th. Weiss Ratings raised shares of DaVita from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 5th. Finally, Barclays increased their target price on shares of DaVita from $218.00 to $224.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 5th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $221.75.

DaVita Profile

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source